PMA P160050S006
- Device
- Barricaid Annular Closure Device
- Applicant
- Intrinsic Therapeutics
- PMA number
- P160050
- Supplement
- S006
- Product code
- QES
- Decision date
- 2020-05-19
- Generic name
- Reherniation reduction device
- Approval order statement
- Approval of the revised protocol for the post-approval study (PAS) protocol.
Current openFDA PMA Record#
- Device
- Barricaid Annular Closure Device
- Applicant
- Intrinsic Therapeutics
- PMA number
- P160050
- Supplement
- S006
- Product code
- QES
- Generic name
- Reherniation reduction device
- Decision date
- 2020-05-19
- Decision code
- APPR
- Date received
- 2020-04-22
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Postapproval Study Protocol
- Approval order statement
- Approval of the revised protocol for the post-approval study (PAS) protocol.